SIRT-1 ACTIVITY IN PBMC FROM PATIENTS WITH SPONDYLOARTHRITIS - PRELIMINARY RESULT
D. Wendling; E. Delattre; W. Abbas; X. Guillot; M. Godfrin-Valnet; K.A. Khan; E. Toussirot; L. Baud; C. Prati; G. Herbein
2014 |
|
Sirt1 activity in peripheral blood mononuclear cells from patients with rheumatoid arthritis
D. Wendling; C. Vidon; W. Abbas; X. Guillot; E. Toussirot; G. Herbein
2014 |
10.1016/j.jbspin.2014.02.006 |
Sirt1 and osteoarthritis. Comments on the paper by Gabay etal.: ``Sirt1-deficient mice exhibit an altered cartilage phenotype'' Joint Bone Spine 2013
D. Wendling; G. Herbein
2014 |
10.1016/j.jbspin.2013.11.005 |
Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation
E. Limagne; M. Thibaudin; R. Euvrard; H. Berger; P. Chalons; F. Vegan; E. Humblin; R. Boidot; C. Rebe; V. Derangere; S. Ladoire; L. Apetoh; D. Delmas; F. Ghiringhelli
2017 |
10.1016/j.celrep.2017.04.004 |
Sirtuin-1 controls Th17 differentiation and Th17-dependent tumor growth by its capacity to deacetylate Stat3
E. Limagne; R. Euvrard; M. Thibaudin; P. Chalons; F. Vegran; H. Berger; L. Apetoh; F. Ghiringhelli; D. Delmas
2015 |
|
Site- specific near- infrared fluorescent labelling of proteins on cysteine residues with meso- chlorosubstituted heptamethine cyanine dyes
C. Canovas; P.S. Bellaye; M. Moreau; A. Romieu; F. Denat; V. Goncalves
2018 |
10.1039/c8ob02646g |
Site-specific Bimodal Labeling of Proteins on Cysteine Residues with Chlorotetrazines
C. Canovas; M. Moreau; C. Bernhard; F. Denat; V. Goncalves
2017 |
|
Site-specific Bimodal Labeling of Proteins on Cysteine Residues with Chlorotetrazines
C. Canovas; M. Moreau; C. Bernhard; F. Denat; V. Goncalves
2017 |
|
Site-Specific Dual Labeling of Proteins on Cysteine Residues with Chlorotetrazines
C. Canovas; M. Moreau; C. Bernhard; A. Oudot; M. Guillemin; F. Denat; V. Goncalves
2018 |
10.1002/anie.201806053 |
Site-Specific Dual-Labeling of a VHH with a Chelator and a Photosensitizer for Nuclear Imaging and Targeted Photodynamic Therapy of EGFR-Positive Tumors
E. Renard; E.Collado Camps; C. Canovas; A. Kip; M. Gotthardt; M. Rijpkema; F. Denat; V. Goncalves; S.A.M. van Lith
2021 |
10.3390/cancers13030428 |
Site-Specific, Platform-Based Conjugation Strategy for the Synthesis of Dual-Labeled Immunoconjugates for Bimodal PET/NIRF Imaging of HER2-Positive Tumors
P. Adumeau; R. Raave; M. Boswinkel; S. Heskamp; H.J.C.T. Wessels; A.J. van Gool; M. Moreau; C. Bernhard; L. Da Costa; V. Goncalves; F. Denat
2022 |
10.1021/acs.bioconjchem.2c00049 |
Six children born after 15 ovarian tissue transplantations: the French protocol for the development of ovarian tissue autograft in order to restore ovarian function (DATOR)
C. Amiot; J.B. Pretalli; S. Frontczak; P. Piver; C. Roux; D.A.T.O.R. Grp
2017 |
|
Six children born after 15 ovarian tissue transplantations: the French protocol for the development of ovarian tissue autograft in order to restore ovarian function (DATOR)
C. Amiot; J.B. Pretalli; S. Frontczak; P. Piver; C. Roux; D.A.T.O.R. Grp
2017 |
|
SIX-MONTH MORTALITY OF CIRRHOTIC PATIENTS WHO SURVIVED INTENSIVE CARE: A META-ANALYSIS
D. Weil; V. Di Martino; E. Levesque; M. McPhail; R. Cavallazzi; E. Theocharidou; E. Cholongitas; A. Galbois; H.C. Pan; C. Karvellas; B. Sauneuf; R. Robert; J. Fichet; G. Piton; G. Capellier; T. Thevenot; M.E.T.A.R.E.A.C.I.R. Grp
2015 |
10.1016/S0168-8278(15)30368-8 |
Six-month patient-reported outcome (PRO) results from AQUARiUS, a prospective, observational, multicenter phase 4 study in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving abiraterone acetate plus prednisone (AAP) or e
A.Thiery Vuillemin; M.Hvid Poulsen; L.M. Dourthe; R. Trepiakas; E. Lagneau; E.Pasquale Pintus; D. Beal-Ardisson; A.Jane Birtle; G. Ploussard; H. Besson; M. Lukac; P. Robinson; A.Helen Reid
2018 |
|
Six-month patient-reported outcome (PRO) results from AQUARiUS, a prospective, observational, multicenter phase 4 study in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving abiraterone acetate plus prednisone (AAP) or e
A.Thiery Vuillemin; M.Hvid Poulsen; L.M. Dourthe; R. Trepiakas; E. Lagneau; E.Pasquale Pintus; D. Beal-Ardisson; A.Jane Birtle; G. Ploussard; H. Besson; M. Lukac; P. Robinson; A.Helen Reid
2018 |
|
Six-phase soft-switching Interleaved Boost Converter based on SiC semiconductor and coupled inductor for Fuel Cell Vehicles
H. Wang; A. Gaillard; D. Hissel
2017 |
|
Six-phase soft-switching Interleaved Boost Converter based on SiC semiconductor and coupled inductor for Fuel Cell Vehicles
H. Wang; A. Gaillard; D. Hissel
2017 |
|
Six-Year Outcomes after Non-Resective Mitral Valve Repair with Artificial Chordae Using Removable Clips
R. Chopard; A. Perrotti; C. Durst; N. Meneveau; L. Stoica; S. Chocron
2014 |
|
Six-Year Outcomes after Non-Resective Mitral Valve Repair with Artificial Chordae Using Removable Clips
R. Chopard; A. Perrotti; C. Durst; N. Meneveau; L. Stoica; S. Chocron
2014 |
|
Six-Year Outcomes After Non-Resective Mitral Valve Repair with Artificial Chordae Using Removable Clips
A. Perrotti; C. Romain; C. Durst; L. Stoica; N. Meneveau; S. Chocron
2014 |
|
Six-Year Outcomes After Non-Resective Mitral Valve Repair with Artificial Chordae Using Removable Clips
A. Perrotti; C. Romain; C. Durst; L. Stoica; N. Meneveau; S. Chocron
2014 |
|
Six-Year Outcomes after Non-Resective Mitral Valve Repair with Artificial Chordae Using Removable Clips
R. Chopard; A. Perrotti; C. Durst; N. Meneveau; L. Stoica; S. Chocron
2014 |
|
Sixth international meeting of the French-speaking paediatric palliative care network
S. Frache; M.L. Viallard
2015 |
10.1016/j.medpal.2015.08.003 |
Size and shape effects on the thermodynamic properties of nanoscale volumes of water
B.A. Strom; J.M. Simon; S.K. Schnell; S. Kjelstrup; J. He; D. Bedeaux
2017 |
10.1039/c7cp00874k |
